Today, one year post-infusion, the little girl who was nearly paralyzed on her right side can lift both arms to catch a ball. She talks up a storm. And she can run - fast. Two months post-infusion, Chloe's physical therapist, Dottie Waldo, was shocked at the recovery of movement in Chloe's hands and arms, saying "I've never seen anything turn around this fast." In fact, Chloe Levine has progressed so much that she no longer needs physical or speech therapy.
"Regenerative therapies using cord blood stem cells are currently being researched for conditions including traumatic brain injury, cerebral palsy, stroke, type 1 diabetes, heart defects and hearing loss," said Heather Brown, vice president of scientific and medical affairs for CBR, the global leader in the collection and preservation of newborn stem cells from umbilical cord blood. "Research indicates these cells have demonstrated the ability to go to damaged sites in the body and help induce healing. And the re-infusion of one's own stem cells back into the body carries no risk of tumor formation or immune response."
Chloe Levine will begin preschool in the fall. It's yet another milestone, as Chloe no longer qualifies for special needs services at school. That simple fact is something her mom, Jenny Levine, calls "a joy beyond words."
"Chloe's story demonstrates that cord blood education isn't just a good idea - it's good health policy," said David Zitlow, senior vice president, public affairs for CBR. "The Institute of Medicine recommends that all pregnant women should be educated about cord blood stem cells early enough in pregnancy that they can make an informed decision about the options to preserve these valuable cells."
Recently, U.S. Rep. Jackie Speier (D-Ca) introduced HR 2107,
|SOURCE Cord Blood Registry|
Copyright©2009 PR Newswire.
All rights reserved